Yi Kang

Title: Yi Kang - Innovator in Drug Synthesis

Introduction

Yi Kang is a notable inventor based in Beijing, China. He has made significant contributions to the field of drug synthesis, particularly with his innovative methods for preparing pharmaceuticals. His work is characterized by a focus on improving the quality and yield of drug products.

Latest Patents

Yi Kang holds a patent for a method of preparing lornoxicam. This method involves using specific raw materials, including 6-chloro-4-hydroxy-2-methyl-2-H-thieno[2,3-e]-1,2-thiazine methyl carboxylate-1,1-dioxide and 2-aminopyridine, along with xylene as a solvent. The process includes mixing the raw materials and solvent, adding a stabilizer, and subjecting the mixture to ammonolysis. The method emphasizes the use of p-toluenesulfonic acid as a stabilizer to enhance the reaction conditions, ultimately improving the product's quality and yield.

Career Highlights

Yi Kang is currently employed at Beijing Jincheng Taier Pharmaceutical Co., Ltd. His role in the company allows him to apply his expertise in drug synthesis and contribute to the development of new pharmaceutical products. His innovative approach has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Yi Kang collaborates with talented colleagues, including Zhen Liu and Dongye Xing. Their combined efforts in research and development foster an environment of innovation and progress within their field.

Conclusion

Yi Kang's contributions to drug synthesis exemplify the impact of innovation in the pharmaceutical industry. His patented method for preparing lornoxicam showcases his commitment to enhancing drug quality and efficiency. Through his work, Yi Kang continues to advance the field of pharmaceutical sciences.